|
|
|
Volumn 23, Issue 5 SUPPL. 10, 1996, Pages 32-35
|
|
Gemcitabine safety overview
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALKALINE PHOSPHATASE;
AMINOTRANSFERASE;
ANTIEMETIC AGENT;
ASPARTATE AMINOTRANSFERASE;
BILIRUBIN;
CREATININE;
CYTOTOXIC AGENT;
DOCETAXEL;
GEMCITABINE;
HEMOGLOBIN;
IRINOTECAN;
NAVELBINE;
NITROGEN;
PACLITAXEL;
PARACETAMOL;
SEROTONIN 3 ANTAGONIST;
TOPOTECAN;
UREA;
BONE MARROW SUPPRESSION;
CLINICAL TRIAL;
EDEMA;
FEVER;
GASTROINTESTINAL SYMPTOM;
GRANULOCYTOPENIA;
HUMAN;
HYPOTENSION;
INFLUENZA;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
NEPHROTOXICITY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RASH;
REVIEW;
ANTIMETABOLITES, ANTINEOPLASTIC;
DEOXYCYTIDINE;
HUMANS;
NEOPLASMS;
|
|
EID: 0029808659
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (103)
|
|
References (0)
|
